Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Peramivir in Hospitalized Influenza
NCT00957996Phase 3Completed
- Sponsor
- BioCryst Pharmaceuticals, Inc.
- Start
- Oct 2009
- Primary completion
- Oct 2010
- Modality
- Orthosteric Ligands
- Countries
- 6
01
Overview
A Phase 3 trial of peramivir in influenza, sponsored by BioCryst Pharmaceuticals, Inc.. Started Oct 2009; status: completed.
02
Drugs
peramivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00957996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00957996.